ClinicalTrials.gov
ClinicalTrials.gov Menu

Electronic Feedback on Diabetic Care to General Practitioners

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01009528
Recruitment Status : Completed
First Posted : November 6, 2009
Last Update Posted : November 9, 2009
Sponsor:
Information provided by:
University of Aarhus

Brief Summary:
The aim of this study is to determine whether electronic feedback to general practitioners on quality of Type 2-Diabetes care increases the quality of care measured on process and outcome measures contained in the national guidelines. Effect evaluation will be performed using a mixed method design.

Condition or disease Intervention/treatment Phase
Type 2 Diabetes Device: Electronic feedback system on diabetes care Not Applicable

Detailed Description:

Background: In an effort to optimize diabetes care in general practice, an electronical feedback system has been developed. The system will be evaluated both quantitative and qualitative.

Method: The general practitioners (GP´s) of the Region of Southern Denmark have been randomised to either admission or no admission to the electronic feedback system. The system was launched 1/3-2007 and ran for one year prior to evaluation.

Quantitative evaluation by assessment of the following end-points: Patients Hba1c-level, number of patients who have had their hba1c-level measured within the last year, cholesterol-level and number of patients who have had an eye examination within the last year.

Qualitative evaluation by interviewing GP´s who have had admission to the system.

Qualitative data have been collected through interviews with intervention GPs, designed to uncover motivational factors as well as barriers concerning the use of feedback on chronic care in general practice. Data are being analyzed.

Quantitative data are being gathered. Perspective: This project will shed light on the value of electronic feedback systems within chronic care in general practice.

Based on this project it will be possible to set up a system for automatic electronic monitoring and feedback of the quality of care in general practice, taking motivational factors of the GP s into account during implementation.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2458 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Development and Evaluation of Electronic Feedback, a Tool for Quality Assurance of the Diabetic Care in General Practice
Study Start Date : March 2007
Actual Primary Completion Date : June 2008
Actual Study Completion Date : November 2009

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention
Admission to electronic feedback system
Device: Electronic feedback system on diabetes care
An electronic feedback system was introduced in randomized primary care clinics providing an overview of quality of care. The intervention ran for 15 months.
Other Names:
  • Electronic feedback system
  • Decission support system

No Intervention: control
Control group. No special attention



Primary Outcome Measures :
  1. Outcome and process measures from the danish diabetes guideline [ Time Frame: 1/3 2007-1/6 2008 ]

Secondary Outcome Measures :
  1. Interview data concerning the impact of the electronic feedback system in the intervention clinics [ Time Frame: 1/3 2007-1/6 2008 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Prevalent Type 2-diabetes as confirmed by Primary Care Physician.
  • Patient alive throughout the intervention period.
  • GP actively working throughout the intervention period (not retired).

Exclusion criteria:

  • death during intervention
  • moved out of geographic area during intervention
  • GP retired during intervention

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01009528


Locations
Denmark
Dept. of General Medicine, Institute of Public Health, Aarhus University
Aarhus, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Study Director: Torsten Lauritzen, MD, Dr. Med. Professor